Your session is about to expire
← Back to Search
Combined Infusion System for Hepatic Cancer
Study Summary
This trial is for adults with colorectal cancer metastatic to the liver or intrahepatic cholangiocarcinoma who will receive the Medtronic SynchroMed II programmable pump combined with the Intera tapered catheter for hepatic artery infusion (HAI) of a standard chemotherapy (FUDR). The primary objective is to assess the safety of using this pump/catheter combination.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I am getting a pump for my inoperable cancer that responds to chemo, or I am having surgery with planned chemo via a pump afterwards.My cancer started in the colon or rectum and has spread to the liver, or I have cancer that began in the liver's bile ducts.I currently have an active infection.Both my cancer doctors agree I should get chemotherapy through a pump.
- Group 1: Hepatic Artery Infusion (HAI) Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the total number of participants currently engaged in this clinical trial?
"Affirmative. Clinicaltrials.gov states that this experiment, which was first published on the 8th of February 2021, is presently recruiting volunteers. Approximately 100 subjects must be recruited from 1 specific site."
Are individuals currently being accepted to participate in this clinical research?
"Indeed, the clinicaltrials.gov page denotes this medical experiment is presently in recruitment phase. It was first launched on February 8th 2021 and most recently updated on July 14th 2022. An even 100 patients are sought from a single location for participation."
Share this study with friends
Copy Link
Messenger